Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

16.330
-0.180-1.09%
Volume:6.40M
Turnover:104.36M
Market Cap:43.37B
PE:10.99
High:16.500
Open:16.440
Low:16.100
Close:16.510
52wk High:28.232
52wk Low:14.505
Shares:2.66B
HK Float Shares:538.00M
Volume Ratio:0.96
T/O Rate:1.19%
Dividend:0.46
Dividend Rate:2.79%
EPS(LYR):1.486
ROE:6.95%
ROA:1.40%
PB:0.76
PE(LYR):10.99
PS:0.87

Loading ...

Fosun Pharma's Subsidiary Sees Regulatory Acceptance for Denosumab Biosimilar Candidate HLX14

Stock News
·
Sep 11

Fosun Pharma Buys Back 1.34 Million H-Shares for HKD 21.86 Million, Raising Treasury Stock to 14.37 Million Shares

Bulletin Express
·
Sep 11

Fosun Pharma Spends Approximately HK$21.86 Million on Share Buyback

Stock News
·
Sep 11

Pharmaceutical Firms Divest Assets to Bolster Core Operations

Deep News
·
Sep 09

Fosun Pharma's New Oral Drug for Vitiligo Gets Green Light for Phase III Trials

Deep News
·
Sep 09

Fosun Pharma Repurchases 152,500 H-Shares for HK$2.63 Million on 9 September 2026

Bulletin Express
·
Sep 09

Fosun Pharma Spends HK$2.63 Million Buying Back Shares on September 9

Stock News
·
Sep 09

Sinopharm Group Stock Slips 2.1% in Hong Kong

Dow Jones
·
Sep 09

Fosun Pharma Receives NMPA Approval to Launch Phase II/III Trial for Dual JAK/TYK2 Inhibitor FXS5626 in Non-Segmental Vitiligo

Bulletin Express
·
Sep 08

Shanghai Fosun Pharma - Receives Nmpa Approval for Phase Ii/Iii Clinical Trial of Fxs5626

THOMSON REUTERS
·
Sep 08

Fosun Pharma's Subsidiary Obtains Regulatory Nod for FXS5626 Tablet Trial in Vitiligo Indication

Stock News
·
Sep 08

Fosun Pharma Repurchases 70,000 H Shares for HKD 1.18 Million, Trimming Free Float by 0.01%

Bulletin Express
·
Sep 07

Fosun Pharma Spends HK$1.18M on Share Buyback on September 7

Stock News
·
Sep 07

Sinopharm Group Stock Rallies 0.9% in Hong Kong

Dow Jones
·
Sep 07

Fosun Pharmaceutical Extends Deadline of 81 Million Yuan Shareholder Loans to Fuyun Health; Shares Up 7%

MT Newswires Live
·
Sep 07

AI-Powered Drug Discovery Heats Up as Innovative Medicines Race Accelerates in Hong Kong Markets

Stock News
·
Sep 07

Shanghai Fosun Pharma 2196.hk Says it Plans to Buy Back up to HK$1Bln of Company H-Shares

THOMSON REUTERS
·
Sep 06

Fosun Pharma Announces HK$1.00 Billion H-Share Buyback Plan for 2026

Bulletin Express
·
Sep 06

Fosun Pharma's Unit to Trim Stake in Gland Pharma via Share Sale

Stock News
·
Sep 06

Sinopharm Group Stock Advances 1.5% in Hong Kong

Dow Jones
·
Sep 04